Zentalis Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
⚲
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Zentalis Pharmaceuticals Inc
✚
CIK #0001725160
EDGAR Form CIK 2011 - 2026
10-K [0001725160]
10-Q [0001725160]
3 [0001725160]
4 [0001725160]
8-K [0001725160]
D [0001725160]
SC 13D [0001725160]
SC 13G [0001725160]
Form 13D/13G Filer Form 13D/13G Subject Filed
Squadron Capital Management LLC Zentalis Pharmaceuticals Inc [2026-03-03]
5AM Opportunities II GP LLC Zentalis Pharmaceuticals Inc [2025-12-30]
Barclays PLC Zentalis Pharmaceuticals Inc [2025-11-12]
Millennium Management LLC Zentalis Pharmaceuticals Inc [2025-02-04]
Walters William T Zentalis Pharmaceuticals Inc [2024-12-10]
Citadel Advisors LLC Zentalis Pharmaceuticals Inc [2023-11-17]
Eventide Asset Management LLC Zentalis Pharmaceuticals Inc [2023-10-10]
Tybourne Capital Management HK Ltd Zentalis Pharmaceuticals Inc [2023-02-14]
Capital International Investors Zentalis Pharmaceuticals Inc [2023-02-13]
State Street Corp Zentalis Pharmaceuticals Inc [2023-02-07]
View All
Form 3/4/5 Subject 2011 - 2026
Myers Scott Dunseth
Zentalis Pharmaceuticals Inc
Kariuki Enoch
Johnson David Michael
Skvarka Jan
Walker Luke Nathaniel
Campbell Shannon
Vultaggio Vincent
Eastland Julia Marie
Bruns Ingmar
Bucher James B
Walters Group
Walters Susan Berkley
Walters William Thurman
Matrix Capital Management Company LP
GOEL David E
Paul Andrea
Lackner Mark
Gallagher Cam
Hausman Diana
Epperly Melissa B
Blackwell Kimberly
Bunker Kevin D
Brownstein Carrie
Roth Iris
Sun Anthony Y
Voliotis Dimitris
Pinto Alexis
Viking Global Opportunities GP LLC
Viking Global Investors LP
Viking Global Opportunities Illiquid Investments Sub-Master
Viking Global Opportunities Portfolio GP LLC
Halvorsen Ole Andreas
Shabet Rose Sharon
Ott David C
Recurium Equity LLC
Takhar Karan S
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
2026-02-10 Sell 6,894 $2.42 16,683
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
2026-02-09 Sell 335 $2.39 801
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
2026-02-09 Sell 889 $2.39 2,125
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
2026-02-09 Sell 3,379 $2.39 8,076
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
2026-02-06 Sell 7,866 $2.43 19,114
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
2026-02-06 Sell 2,962 $2.43 7,198
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
2026-02-06 Sell 29,951 $2.43 72,781
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
2026-02-03 Sell 556 $2.52 1,401
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
2026-02-02 Sell 2,540 $2.55 6,477
Zentalis Pharmaceuticals Inc ZNTL
Stock Option (Right to Buy) · derivative
2026-01-08 Grant 365,000 $0.00
Zentalis Pharmaceuticals Inc ZNTL
Stock Option (Right to Buy) · derivative
2026-01-08 Grant 100,000 $0.00
Zentalis Pharmaceuticals Inc ZNTL
Stock Option (Right to Buy) · derivative
2026-01-08 Grant 100,000 $0.00
Zentalis Pharmaceuticals Inc ZNTL
Stock Option (Right to Buy) · derivative
2026-01-08 Grant 775,000 $0.00
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
2025-12-31 Buy 6,459,973 $1.20 7,751,968
Zentalis Pharmaceuticals Inc ZNTL
Common Stock, par value $0.001 per share
2025-12-15 Sell 7,500,000 $1.33 9,975,000
Zentalis Pharmaceuticals Inc ZNTL
Stock Option (Right to Buy) · derivative
2025-10-01 Grant 400,000 $0.00
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
2025-06-17 Grant 57,603 $0.00
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
2025-06-17 Grant 57,603 $0.00
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
2025-06-17 Grant 57,603 $0.00
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
2025-06-17 Grant 57,603 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com